Myeloproliferative Disorders: all 640 studies
Page 4 of 7. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.
- A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative NeoplasmsCompletedNCT05444530Phase 1
- Role of Monocytes Sub-populations in Thrombosis Associated With Myeloproliferative Neoplasms (MonSThr)CompletedNCT05419648
- Characteristics of Patients With Philadelphia Negative Myeloproliferative Neoplasms at Assiut University HospitalStatus unknownNCT05401864
- Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell TransplantsActive, not recruitingNCT05364762Phase 2
- Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative Neoplasms in AdultsStatus unknownNCT05282719Phase 2
- MargheRITA (Remote Intelligence for Therapeutic Adherence)CompletedNCT05260203Not applicable
- Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With MyeloproliferativeCompletedNCT05153343Phase 1/2
- Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative NeoplasmsTerminatedNCT05127174Phase 1
- Study of Flonoltinib Maleate Tablets in the Treatment of Proliferative Bone Marrow TumorsWithdrawnNCT05115344Phase 1
- PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell MalignanciesTerminatedNCT05107856Phase 1
- Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted GraftActive, not recruitingNCT05088356Phase 1
- Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT StudyCompletedNCT05053100
- In Vitro Drug Sensitivity Testing of Fresh Human SamplesStatus unknownNCT05001386Not applicable
- MASCOT Registry of Patients With Myeloproliferative Neoplasms Associated Splanchnic Vein ThrombosisCompletedNCT04994158
- A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative NeoplasmsWithdrawnNCT04955938Phase 1
- Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid MalignanciesCompletedNCT04943757Phase 2
- Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)CompletedNCT04942730Phase 2
- Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative NeoplasmCompletedNCT04926194Phase 2
- Acquired Pyruvate Kinase Deficiency In Clonal Myeloid NeoplasmsCompletedNCT04902833
- Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.TerminatedNCT04866056Phase 1/2
- Study of Pulmonary Hypertension in Patients With Chronic Myeloproliferative Disorders at Sohag University HospitalStatus unknownNCT04843475
- Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood DisordersActive, not recruitingNCT04761770Phase 2
- Remotely Administered Diet Intervention to Impact Symptom Burden in Myeloproliferative NeoplasmCompletedNCT04744974Phase 2
- SARS-CoV-2 Donor-Recipient Immunity TransferCompletedNCT04666025
- A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid NeoplasmsTerminatedNCT04637009Phase 1
- Outcomes in Patients With Myeloproliferative Neoplasm and Splanchnic Vein ThrombosisStatus unknownNCT04631458
- Thrombosomes® in Bleeding Thrombocytopenic Patients StudyTerminatedNCT04631211Phase 2
- Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative NeoplasmsWithdrawnNCT04629651Phase 1/2
- Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCTCompletedNCT04629430Not applicable
- A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase InhibitorsCompletedNCT04605211Not applicable
- Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 MutationsActive, not recruitingNCT04603001Phase 1
- A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor TreatmentActive, not recruitingNCT04576156Phase 3
- Study of Selinexor in Combination With Ruxolitinib in MyelofibrosisActive, not recruitingNCT04562389Phase 3
- Anticoagulation in Gastroesophageal Varices and JAK2 MutationStatus unknownNCT04527666
- Gastroesophageal Varices in CavernomaStatus unknownNCT04525768
- Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)Active, not recruitingNCT04509700Phase 2
- Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL MutationsActive, not recruitingNCT04493138Phase 1/2
- Haplo Peripheral Blood Sct In GVHD PreventionCompletedNCT04473911Phase 1
- HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell TransplantationWithdrawnNCT04464889Phase 1
- COVID-19 Epidemic and Patients With Myeloproliferative NeoplasiasCompletedNCT04416438
- Myeloproliferative Neoplasms (MPN) and COVID-19CompletedNCT04385160
- Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).Active, not recruitingNCT04378855
- A Study of TQ05105 Tablets in Subjects With Myeloproliferative NeoplasmsCompletedNCT04339400Phase 1
- Value of CD26 Positive Leukemic Stem Cell in Myeloproliferative NeoplasmStatus unknownNCT04312607
- Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or IntoleranceActive, not recruitingNCT04285086Phase 3
- Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid NeoplasmsActive, not recruitingNCT04279847Phase 1
- Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT04250051Phase 1
- Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm PatientsCompletedNCT04243122Phase 2
- Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative NeoplasmsCompletedNCT04192916
- Evaluation of New Biomarkers of Thrombosis in Myeloproliferative NeoplasmsCompletedNCT04177576
- CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic MalignanciesStatus unknownNCT04156256Early Phase 1
- European Registry for Myeloproliferative Neoplasms (MPNs) - Update of ERNEST StudyCompletedNCT04153305
- An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML)TerminatedNCT04113616Phase 1/2
- Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment ResultsStatus unknownNCT04060485
- Dual Vaccine Trial in Myeloproliferative NeoplasmsCompletedNCT04051307Phase 1/2
- A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmActive, not recruitingNCT04041050Phase 1
- PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT04022785Phase 1
- Aquagenic Pruritus in Myeloproliferative NeoplasmsCompletedNCT04018209
- Collect and Assess Tissue Samples From Subjects With Hematologic MalignancyCompletedNCT04014764
- Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCTStatus unknownNCT03977103Phase 2
- Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCTWithdrawnNCT03939585Phase 1
- MPN Podcast Pilot StudyCompletedNCT03907774
- The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility PhaseCompletedNCT03907436Not applicable
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
- Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.CompletedNCT03869476Not applicable
- Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaActive, not recruitingNCT03862157Phase 1/2
- Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative NeoplasmsCompletedNCT03808805Phase 3
- Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell TransplantWithdrawnNCT03807063Phase 1
- CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic MalignanciesStatus unknownNCT03795779Early Phase 1
- Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell TransplantActive, not recruitingNCT03779854Phase 2
- Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)CompletedNCT03745378
- The Feasibility of Delivering Consumer-based Meditation Applications to Myeloproliferative Neoplasm PatientsCompletedNCT03726944Not applicable
- Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative NeoplasmsCompletedNCT03688490
- Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell TransplantActive, not recruitingNCT03622788Phase 1/2
- Registry of Patients With MPNs in TaiwanActive, not recruitingNCT03618485
- Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell TransplantationWithdrawnNCT03602898Phase 2
- Study of the Safety and Efficacy of APR-246 in Combination With AzacitidineCompletedNCT03588078Phase 1/2
- CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative NeoplasmsCompletedNCT03566446Phase 1
- The Role of Ruxolitinib in Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative NeoplasmStatus unknownNCT03558607Phase 1/2
- EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute LeukemiaTerminatedNCT03519984Phase 1
- Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell TransplantWithdrawnNCT03438344Phase 2
- TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic AcidCompletedNCT03397173Phase 2
- Cardiac Changes in Myeloproliferative NeoplasmsStatus unknownNCT03177928Not applicable
- 18F-FLT (PET/CT) in Pediatrics With Myeloproliferative NeoplasmsTerminatedNCT03121599Not applicable
- CO-Rebreathing in Comparison to Isotopic Red Cell Volume Determination in the Diagnosis of Primitive and Secondary PolycythemiaCompletedNCT03008642Not applicable
- Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02960646Phase 1
- Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)CompletedNCT02953704
- Efficacy of Heat-shock Protein (HSP) Inhibitors in Myeloproliferative Syndromes (MPS)CompletedNCT02873832
- Role of the Circulating Procoagulants Microparticles in the Hypercoagulability of MNP Ph1-CompletedNCT02862366
- Clinical and Therapeutic Impact of Molecular Markers in Myeloproliferative DisordersStatus unknownNCT02823210
- Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative NeoplasmsCompletedNCT02823184
- PTCy and Ruxolitinib GVHD Prophylaxis in MyelofibrosisCompletedNCT02806375Phase 1/2
- The National Myelodysplastic Syndromes (MDS) StudyCompletedNCT02775383
- Exploring the Mechanisms of Resistance of Stem Cells Myeloproliferative Opposite of Tyrosine Kinase Inhibitors in 3d Model Niche EndostealTerminatedNCT02766153
- Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative DisordersWithdrawnNCT02663648
- Pulmonary Hypertension in Patients With Myeloproliferative NeoplasmsCompletedNCT02580903
- Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)WithdrawnNCT02564536Phase 1
- Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015CompletedNCT02320656Not applicable
- Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutationCompletedNCT02311569Phase 2
- Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)CompletedNCT02252159